The Erickson Foundation, Catonsville, MD 21228, USA.
J Clin Densitom. 2010 Apr-Jun;13(2):204-9. doi: 10.1016/j.jocd.2010.01.004. Epub 2010 Mar 29.
It has been estimated that up to 45% of men in the United States have low bone density. Yet, only a few studies have examined men's knowledge of bone health and disease. Men's knowledge of sex-specific issues related to osteoporosis is especially not well understood. We surveyed 1535 community-dwelling men with a mean age of 79 yr. The assessed risk factors included a current diagnosis of low bone mass, positive history for fracture, recent level of physical activity, and current medications with the potential to affect bone health. Knowledge about male risk factors for osteoporosis was also assessed, including the effects of advancing age, frame size, fracture risk, calcium and Vitamin D supplementation, low testosterone level, and treatment for prostate cancer. Within this sample, only 11% of the men reported a current diagnosis of low bone mass, whereas 11% reported a prior hip fracture. Only 5% of the sample reported taking some type of Food and Drug Administration-approved medication for osteoporosis. In the aggregate, the participating men answered only 39% of the 6 male osteoporosis-knowledge questions correctly. It is imperative that bone health promotion campaigns that have educated many women effectively now expand their focus to advance the bone health of men also.
据估计，美国高达 45%的男性存在骨密度低的问题。然而，仅有少数研究调查了男性对骨骼健康和疾病的了解程度。男性对与骨质疏松症相关的特定性别问题的了解尤其不足。我们调查了 1535 名居住在社区的男性，他们的平均年龄为 79 岁。评估的风险因素包括当前的低骨量诊断、骨折病史、近期身体活动水平以及当前可能影响骨骼健康的药物。还评估了男性骨质疏松症风险因素的知识，包括年龄增长、体型、骨折风险、钙和维生素 D 补充、低睾酮水平以及前列腺癌治疗的影响。在这个样本中，只有 11%的男性报告了当前的低骨量诊断，而 11%的男性报告了先前的髋部骨折。只有 5%的样本报告服用了某种经美国食品和药物管理局批准用于治疗骨质疏松症的药物。总体而言，参与调查的男性仅正确回答了 6 个男性骨质疏松症知识问题中的 39%。现在，必须确保那些成功教育了许多女性的骨骼健康促进活动扩大其关注范围，以提高男性的骨骼健康水平。
